City of Hope’s cell experiments show more effective genetic "cuts" that could one day become the foundation of new and more effective gene therapies for HIV and sickle cell disease.
City of Hope’s cell experiments show more effective genetic ‘cuts’ that could one day become the foundation of new and more effective gene therapies.
The National Cancer Institute awarded a grant to City of Hope with the goal of sparking passion for science among underrepresented minority youth in neighboring communities. YES2SUCCESS comprises a pipeline of outreach activities and hands-on participation in research from sixth grade through the undergraduate years.
The family of SNARE proteins are an essential part of the body’s complex transport system, helping to regulate diverse biological processes. Thurmond investigates the role that certain members of that family play in metabolism — research that has the potential to result in new therapies for type 1 diabetes.
City of Hope's John Termini, Ph.D., presents research at the American Chemical Society annual meeting that could explain why diabetes patients have an increased risk of developing some forms of cancer.
They come from Amritsar, India; Beijing, China; Circle Pines, Minnesota … and lots of places in between. They are the next generation of diabetes researchers at City of Hope, bringing their diverse backgrounds, fresh perspectives, and youthful drive and enthusiasm to our mission to eliminate type 1 diabetes once and for all.
Sampath Rangasamy, Ph.D., a researcher at City of Hope affiliate TGen, has spent his whole life researching type 1 diabetes, a personal battle since he himself suffers from the disease.
From longtime administrators to veteran faculty to next-generation researchers, so many diabetes specialists smile and mention the name Arthur D. Riggs when asked why they chose City of Hope.
Groundbreaking diabetes researchers Yoko Fujita-Yamaguchi, Ph.D., and Rama Natarajan, Ph.D., are mentoring the next generation of scientists.
Many people struggle with both diabetes and cancer at the same time — none of this is random or coincidental. Rather, it's clear that, from biology to risk factors to treatment options, cancer and diabetes are intimately related in many ways.
Learning about the mechanisms terrestrial bacteria and fungi use to survive in the challenging environment of outer space could give us insights into how to fight disease, as well as how to promote beneficial bacterial growth.
A scientist from City of Hope, an institution with expertise in both diabetes and cancer, will present research on why diabetes patients have an increased risk of developing some forms of cancer.
The Pancreatic Cancer Action Network has awarded two City of Hope researchers — Yuan Chen, Ph.D., and Xiaochun Yu, M.D., Ph.D. — $500,000 Translational Research Grants — a total gift of $1 million.
City of Hope scientists highlighted research successes and presented recent findings at the 2019 American Diabetes Association’s Scientific Sessions.
John Rossi, Ph.D., the Lidow Family Research Chair and professor of the Department of Molecular and Cellular Biology, is the recipient of the 2019 Outstanding Achievement Award presented by the American Society of Gene and Cell Therapy.
City of Hope — widely known as a center for cancer care and research — is also the home of one of the most influential diabetes research programs in the world.
A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” — therapy combined with diagnostics — that target specific tumors and diseases.
A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” – therapy combined with diagnostics – that target specific tumors and diseases.
City of Hope has long been renowned for its expertise in treating cancer and diabetes. But specialists here also are tackling lesser-known but equally devastating diseases that may or may not have an oncologic component.
Debbie Thurmond, Ph.D., delivers and accepts the John K. and Mary E. Davidson Lectureship and Award for Outstanding Diabetes Research